Literature DB >> 15289265

Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.

Mark F Stidworthy1, Stephane Genoud, Wen-Wu Li, Dino P Leone, Ned Mantei, Ueli Suter, Robin J M Franklin.   

Abstract

The reasons for the eventual failure of repair mechanisms in multiple sclerosis are unknown. The presence of precursor and immature oligodendrocytes in some non-repairing lesions suggests a mechanism in which these cells either receive insufficient differentiation signals or are exposed to differentiation inhibitors. Jagged signalling via Notch receptors on oligodendrocyte precursor cells (OPCs) inhibits their differentiation during development and the finding that both notch and jagged are expressed in multiple sclerosis lesions has fostered the view that this signalling pathway may explain remyelination failure. In this study, we show that Notch1 is expressed on adult OPCs and that there are multiple cellular sources of its ligand Jagged1 in a rodent model of remyelination. However, despite their expression, the lesions undergo complete remyelination. To establish whether Notch-jagged signalling regulates the rate of remyelination we compared their expression profiles in young animals with those in older animals, where remyelination occurs more slowly, but could find no correlation between expression and remyelination rate. Finally we found that OPC-targeted Notch1 ablation in cuprizone-treated Plp-creER Notch1(lox/lox) transgenic mice yielded no significant differences in remyelination parameters between knock-out and control mice. Thus, in contrast to developmental myelination, adult expression of Notch1 and Jagged1 neither prevents nor plays a major rate-determining role in remyelination. More generally, the re-expression of developmentally expressed genes following injury in the adult does not per se imply similar function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289265     DOI: 10.1093/brain/awh217

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  67 in total

Review 1.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

2.  Jagged1 signals in the postnatal subventricular zone are required for neural stem cell self-renewal.

Authors:  Yves Nyfeler; Robert D Kirch; Ned Mantei; Dino P Leone; Freddy Radtke; Ueli Suter; Verdon Taylor
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

Review 3.  Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Authors:  Martin Stangel; Corinna Trebst
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

Review 4.  Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.

Authors:  Siming Shen; Patrizia Casaccia-Bonnefil
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

5.  Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.

Authors:  Eva Herrero-Herranz; Luis A Pardo; Gertrude Bunt; Ralf Gold; Walter Stühmer; Ralf A Linker
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

6.  Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.

Authors:  Jin Nakahara; Kohsuke Kanekura; Mikiro Nawa; Sadakazu Aiso; Norihiro Suzuki
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

Review 7.  Neuroprotection and neuroregeneration in multiple sclerosis.

Authors:  Martin Stangel
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 8.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 9.  Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Authors:  Jeffrey K Huang; Stephen P J Fancy; Chao Zhao; David H Rowitch; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

10.  Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.

Authors:  Li He; Q Richard Lu
Journal:  Neurosci Bull       Date:  2013-03-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.